Sichenzia Ross Ference LLP Represents Zynex, Inc. in its $31.0 Million Acquisition of Kestrel Labs
Press Release – New York, NY – December 23, 2021 – Sichenzia Ross Ference LLP announced today that its mergers and acquisitions team represented Zynex, Inc. (NASDAQ ZYXI) in its acquisition of Kestrel Labs, Inc., a laser-based, noninvasive patient monitoring technology company.
Zynex, Inc. acquired 100% of the stock of Kestrel Labs, Inc. The transaction closed at an approximate value of $31.0 million, consisting of $16.0 million in cash and approximately $15.0 million in Zynex common stock.
Zynex, Inc. manufactures and sells noninvasive medical devices for pain management, rehabilitation and patient monitoring.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jay Yamamoto and Glenn Burlingame, tax counsel Michael Savage and associates Ryan Flynn and Zachary Weiss.
- Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
- Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021